ImmunityBio (IBRX) Price to Sales (2015 - 2026)
ImmunityBio's Price to Sales came in at 55.65 for Q2 2026, up 30.3% from 42.71 a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Price to Sales (2015 - 2026) Analysis & Trends
For FY2025, ImmunityBio's Price to Sales was 17.68, down 85.4% from FY2024.
- Price to Sales has declined in each of the last three years.
- Going back by year, Price to Sales was 121.07 in FY2024 (-97.1%), 4105.07 in FY2023 (-53.9%), 8905.65 in FY2022 (+243.9%) and 2589.73 in FY2021 (+13.5%).
- The five-year range for quarterly Price to Sales is 17.68 (Q4 2025) to 12038.11 (Q1 2024).
- Year-over-year, Price to Sales increased in 1 of the last eight quarters, with an average decline of 68.7%.
- The fastest year-over-year change in Price to Sales over five years came in Q1 2024 (growth of 819.4%), and the weakest in Q1 2025 (a decline of 99.3%).
- Business Quant data shows IBRX's Price to Sales at 56.98 (Q1 2026), 17.68 (Q4 2025) and 29.35 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | ImmunityBio | 9.94 Bn | 8.70 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.65 |
| Mar 31, 2026 | 56.98 |
| Dec 31, 2025 | 17.68 |
| Sep 30, 2025 | 29.35 |
| Jun 30, 2025 | 42.71 |
| Mar 31, 2025 | 82.29 |
| Dec 31, 2024 | 121.07 |
| Sep 30, 2024 | 353.55 |
| Jun 30, 2024 | 3,342.61 |
| Mar 31, 2024 | 12,038.11 |
| Dec 31, 2023 | 4,105.07 |
| Sep 30, 2023 | 1,514.85 |
| Jun 30, 2023 | 2,069.38 |
| Mar 31, 2023 | 1,309.31 |
| Dec 31, 2022 | 8,905.65 |
| Sep 30, 2022 | 3,571.83 |
| Jun 30, 2022 | 2,932.32 |
| Mar 31, 2022 | 2,759.63 |
| Dec 31, 2021 | 2,589.73 |
| Sep 30, 2021 | 6,800.93 |
API Access
ImmunityBio Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();